NIH-funded research R01 grant

Understanding how brain signals control energy balance and food intake

Official title: Synaptic and circuit mechanisms of central GLP-1 signaling in energy balance

Funded at Rutgers Biomedical and Health Sciences · NIH-11092860 · Data updated 2026-11-12

This study is looking at how a hormone called GLP-1 in the brain helps control hunger and energy use, with the hope of finding new ways to help people manage obesity.

More Balance research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startJuly 31, 2022
Project endMay 31, 2026
Funding year2025
Award (this year)$485,724
NIH project number5R01DK131452-04
Project IDNIH-11092860 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals struggling with obesity or adult-onset diabetes.

Less likely to help

Patients who do not have issues related to obesity or metabolic disorders may not receive benefit from this research.

What this research studies

This research investigates the role of glucagon-like peptide 1 (GLP-1) in the brain and its effects on regulating energy balance and food intake. By exploring the cellular and circuit mechanisms of GLP-1 signaling in the central nervous system, the study aims to uncover how these signals can suppress feeding and potentially lead to new treatments for obesity. The research employs advanced molecular tools to analyze neuronal activity and connectivity, focusing on specific brain regions involved in energy regulation. Patients may benefit from insights that could lead to more effective obesity interventions.

Why it matters

Potential benefit: If successful, this research could lead to new therapies for obesity and related metabolic disorders.

How similar studies have gone: Previous research has shown promising results in understanding GLP-1 signaling, indicating potential for significant advancements in obesity treatment.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Pang, Zhiping P. — Rutgers Biomedical and Health Sciences
  • Study coordinator: Pang, Zhiping P.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.